Clindamycin Palmitate Hydrochloride used to treat infections caused by bacteria, is a FDA approved generic version of Pfizer’s Cleocin Pediatric.
According to IMS Health data, Clindamycin Palmitate Hydrochloride had sales nearly $59m for the twelve months ended 30 June 2012.
Rising Pharmaceuticals is a finished dosage form generics subsidiary to ACETO Corporation, which markets, sells and distributes products for human health, pharmaceutical ingredients and performance chemicals.